Australian Dairy Nutritionals Group (AHF) AI Stock Analysis

• Market Cap: €27.50M
• Dividend Yield: N/A
• Average Volume (3M): 465.88K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.23
• Revenue Growth: 13.92%
• EPS Growth: 36.28%
• Country: AU
• Employees: N/A
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Packaged Foods
• EPS (TTM): >-0.01
• Shares Outstanding: 743,321,840
• 10 Day Avg. Volume: 385,458
• 30 Day Avg. Volume: 465,878
• PEG Ratio: 0.17
• Price to Book (P/B): 1.33
• Price to Sales (P/S): 4.44
• P/FCF Ratio: -9.19
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 38 Underperform
• Price Target: AU$0.03 ▲(10.00% Upside)

The overall stock score is primarily influenced by the company's weak financial performance, characterized by negative profitability and cash flow challenges. Technical analysis indicates a bearish trend, further impacting the score. The negative P/E ratio and lack of dividend yield contribute to a poor valuation score. These factors collectively result in a low overall stock score.

Positive Factors

Revenue Growth

Strong revenue growth indicates increasing demand for AHF's products, suggesting effective market penetration and potential for future expansion.

Low Leverage

Minimal leverage enhances financial stability, providing AHF with flexibility to invest in growth opportunities without significant debt burden.

Vertically Integrated Operations

Vertical integration allows AHF to maintain high product quality and cost control, supporting its differentiation strategy in competitive markets.

Negative Factors

Negative Profit Margins

Negative profit margins indicate operational inefficiencies and challenges in cost management, potentially impacting long-term profitability and competitiveness.

Cash Flow Challenges

Declining cash generation limits AHF's ability to fund operations and growth initiatives, posing risks to financial health and strategic flexibility.

Negative Return on Equity

Negative ROE suggests inefficiencies in utilizing shareholder funds, which may deter investment and hinder long-term value creation.

Australian Dairy Nutritionals Group Business Overview & Revenue Model

Company Description

Australian Dairy Nutritionals Group (AHF) is a leading player in the Australian dairy industry, specializing in the production and export of high-quality dairy nutritional products. The company operates across several sectors, including infant formula, nutritional powders, and dairy-based ingredients, catering to both domestic and international markets. AHF is committed to sustainability and innovation in dairy farming and product development, ensuring that its offerings meet the highest standards of quality and nutritional value.

How the Company Makes Money

AHF generates revenue primarily through the sale of its dairy nutritional products, including infant formula and nutritional powders, which are sold both domestically and internationally. The company has established significant partnerships with distributors and retailers, enhancing its market reach and driving sales. Key revenue streams include direct sales to consumers, bulk sales to retailers, and exports to overseas markets. Additionally, AHF may benefit from economies of scale in production and supply chain efficiencies, which contribute to its profitability. The company's commitment to quality and innovation also allows it to command premium pricing for its products, further bolstering its revenue.

Australian Dairy Nutritionals Group Financial Statement Overview

Summary

The company is experiencing revenue growth, but profitability remains a significant challenge with negative margins across the board. The balance sheet shows low leverage, which is a strength, but the company struggles with generating returns on equity. Cash flow issues persist, with negative growth and coverage ratios, indicating potential liquidity concerns.

Income Statement

The company has shown a positive revenue growth rate of 34.74% in the latest year, indicating potential recovery. However, the gross profit margin and net profit margin remain negative, reflecting ongoing challenges in profitability. The EBIT and EBITDA margins are also negative, suggesting operational inefficiencies.

Balance Sheet

The debt-to-equity ratio is low at 0.002, indicating minimal leverage, which is a positive aspect. However, the return on equity is negative, showing that the company is not generating returns for shareholders. The equity ratio is relatively stable, suggesting a solid capital structure.

Cash Flow

The company has a negative free cash flow growth rate, indicating declining cash generation capabilities. The operating cash flow to net income ratio is negative, highlighting cash flow challenges. However, the free cash flow to net income ratio is slightly above 1, suggesting some ability to cover net losses with free cash flow.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	7.17M	7.17M	6.18M	5.86M	5.80M	21.30M
Gross Profit	402.79K	-1.42M	-2.15M	-288.23K	-4.36M	-3.27M
EBITDA	-5.14M	-4.30M	-6.26M	-5.95M	-1.29M	-5.34M
Net Income	-5.21M	-5.21M	-7.36M	-9.16M	-4.15M	-6.40M
Balance Sheet
Total Assets	25.09M	25.09M	30.35M	36.24M	44.60M	43.11M
Cash, Cash Equivalents and Short-Term Investments	2.69M	2.69M	6.13M	2.01M	2.43M	6.23M
Total Debt	48.45K	48.45K	2.25M	1.04M	1.09M	6.49M
Total Liabilities	1.44M	1.44M	3.62M	2.72M	4.65M	9.12M
Stockholders Equity	23.85M	23.85M	26.87M	33.59M	16.05M	33.99M
Cash Flow
Free Cash Flow	-3.46M	-3.46M	-4.72M	-7.91M	-6.90M	-7.11M
Operating Cash Flow	-3.28M	-3.28M	-4.44M	-7.05M	-3.80M	-2.03M
Investing Cash Flow	-47.59K	-47.59K	6.73M	6.18M	3.10M	1.07M
Financing Cash Flow	-94.51K	-94.51K	1.80M	449.98K	-3.07M	796.49K

Australian Dairy Nutritionals Group Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.03
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:AHF, the sentiment is Negative. The current price of 0.03 is below the 20-day moving average (MA) of 0.04, below the 50-day MA of 0.04, and below the 200-day MA of 0.04, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 41.37 is Neutral, neither overbought nor oversold. The STOCH value of 8.33 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:AHF.

Australian Dairy Nutritionals Group Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CLV	74 Outperform	AU$116.06M	16.55	10.07%	2.22%	38.25%	361.54%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
BUB	60 Neutral	AU$129.65M	23.39	13.97%	―	28.66%	―
BGA	51 Neutral	€1.62B	-189.61	-0.68%	2.04%	0.49%	-127.84%
NUC	45 Neutral	AU$24.89M	-6.13	-29.43%	―	102.21%	69.47%
NOU	40 Underperform	AU$36.02M	-0.24	―	―	1.03%	-52.56%
AHF	38 Underperform	€27.50M	―	-20.54%	―	13.92%	36.28%

Australian Dairy Nutritionals Group Corporate Events

Australian Dairy Nutritionals Group Announces Director’s Interest Change

Australian Dairy Nutritionals Group has announced a change in the director’s interest, specifically involving Peter Nathan, who has been issued 1,500,000 unlisted options under the company’s Incentive Plan. This change, approved by shareholders at the recent AGM, reflects the company’s strategy to align management interests with shareholder value, potentially impacting the company’s governance and operational focus.

Australian Dairy Nutritionals Issues Unquoted Equity Securities for Employee Incentives

Australian Dairy Nutritionals Limited announced the issuance of 1,500,000 unquoted equity securities in the form of options expiring on November 7, 2030, with an exercise price of $0.04. This issuance is part of an employee incentive scheme, which is not intended to be quoted on the ASX, and reflects the company’s efforts to incentivize and retain employees, potentially impacting its operational efficiency and market positioning.

Australian Dairy Nutritionals Faces Shareholder Pushback at AGM

At the 2025 Annual General Meeting of Australian Dairy Nutritionals Limited, a significant development was the second strike against the adoption of the Remuneration Report, with over 25% of votes cast against it. This outcome indicates potential shareholder dissatisfaction with executive compensation. However, the proposal for a Board Spill Meeting was not approved, meaning no immediate changes to the board are required. The meeting also saw the approval of several resolutions, including the re-election of a director and the issuance of options and performance rights, reflecting ongoing strategic initiatives to strengthen the company’s leadership and financial flexibility.

Australian Dairy Nutritionals Group Hosts 2025 Annual General Meeting

Australian Dairy Nutritionals Limited held its 2025 Annual General Meeting, where the CEO presented to shareholders. The meeting was an opportunity for the company to communicate its current operations and future outlook. This event underscores AHF’s commitment to transparency and engagement with its stakeholders, potentially impacting its market positioning and investor relations.

Australian Dairy Nutritionals Reports Strong Q1 FY26 Performance

Australian Dairy Nutritionals Group reported a consolidated revenue of $1.9 million for the first quarter of fiscal year 2026, with nutritional powder sales contributing $1.3 million. This marks a significant increase in revenue compared to the same period last year, driven by increased distribution of the Future brand in China and contract pack sales. The company also achieved a record production of 67 tonnes, reflecting a strong demand for its products. The Group is focused on expanding its distribution in China and anticipates continued sales and production momentum. Despite a net cash outflow from operations, the financial results are in line with expectations, supporting the company’s strategy to grow as a profitable infant formula export business.

Australian Dairy Nutritionals Group Announces Director’s Interest Change

Australian Dairy Nutritionals Group announced a change in the director’s interest, specifically regarding Peter Nathan’s indirect holdings. The change involved the acquisition of 740,000 fully paid ordinary shares through an on-market trade, reflecting a potential strategic move to strengthen the director’s investment in the company.

Australian Dairy Nutritionals Announces 2025 Annual General Meeting

Australian Dairy Nutritionals Limited has announced its Annual General Meeting (AGM) for shareholders, scheduled for October 30, 2025, in Docklands, Victoria. The company encourages shareholders to submit questions in advance and vote via proxy to facilitate efficient communication. This meeting is an opportunity for stakeholders to engage with the company’s leadership and discuss future directions, reflecting AHF’s commitment to transparency and shareholder engagement.

Director’s Interest Change at Australian Dairy Nutritionals

Australian Dairy Nutritionals Group announced a change in the director’s interest, with Peter Nathan acquiring additional shares through indirect holdings. This transaction, conducted via on-market trades, reflects a strategic adjustment in the director’s investment, potentially impacting the company’s shareholder structure and market perception.